Showing results (81-90 of 110) with videos related to

Sort By:
Pageof 11
Leukemia Research|May 17, 2014
Chronic myeloid leukemia patients who develop grade I/II pleural effusion under second-line dasatinib have better responses and outcomes than patients without pleural effusionAhmet Emre Eskazan, Deniz Eyice, Enes Ali Kurt, et al.
Frontiers in Neurology|March 16, 2026
Unmasking genetic etiologies in neurodevelopmental disorders characterized by Cerebral Palsy: insights from integrative genomic approachesAyca Yigit, Ozlem Akgun-Dogan, Zeynep Ozkeserli, et al.
Biochemical Genetics|January 9, 2025
Status of IKZF1 Deletions in Diagnose and Relapsed Pediatric B-ALL PatientsYücel Erbilgin, Sinem Firtina, Elif Kirat, et al.
Leukemia & Lymphoma|July 3, 2018
Deep sequencing of BCR-ABL1 kinase domain mutations in chronic myeloid leukemia patients with resistance to tyrosine kinase inhibitorsYucel Erbilgin, Ahmet Emre Eskazan, Ozden Hatirnaz Ng, et al.
Disease Markers|August 5, 2010
Prognostic significance of NOTCH1 and FBXW7 mutations in pediatric T-ALLYucel Erbilgin, Muge Sayitoglu, Ozden Hatirnaz, et al.
Plos Biology|November 28, 2012
The nuclear effector of Wnt-signaling, Tcf1, functions as a T-cell-specific tumor suppressor for development of lymphomasMachteld M Tiemessen, Miranda R M Baert, Tom Schonewille, et al.
Hematology (Amsterdam, Netherlands)|October 10, 2017
Third-line treatment with second-generation tyrosine kinase inhibitors (dasatinib or nilotinib) in patients with chronic myeloid leukemia after two prior TKIs: real-life data on a single center experience along with the review of the literatureSeniz Ongoren, Ahmet Emre Eskazan, Veysel Suzan, et al.
Expert Opinion on Pharmacotherapy|August 9, 2016
Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phaseGuray Saydam, Ibrahim Celalettin Haznedaroglu, Leylagul Kaynar, et al.
Hematology (Amsterdam, Netherlands)|July 13, 2018
Frontline nilotinib treatment in Turkish patients with Philadelphia chromosome-positive chronic Myeloid Leukemia in chronic phase: updated results with 2 years of follow-upGuray Saydam, Ibrahim Celalettin Haznedaroglu, Leylagul Kaynar, et al.
Hematology (Amsterdam, Netherlands)|March 1, 2018
Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phaseGuray Saydam, Ibrahim C Haznedaroglu, Leylagul Kaynar, et al.
Pageof 11